| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 7.647 | 27.150 | 25.895 | 22.282 | 22.983 | 32.267 | 39.650 | 54.292 |
| Total Income - EUR | - | - | 7.647 | 27.150 | 25.895 | 22.506 | 22.983 | 32.267 | 39.650 | 54.292 |
| Total Expenses - EUR | - | - | 2.849 | 7.184 | 9.725 | 12.065 | 14.992 | 11.115 | 13.947 | 40.951 |
| Gross Profit/Loss - EUR | - | - | 4.798 | 19.966 | 16.170 | 10.442 | 7.991 | 21.152 | 25.702 | 13.342 |
| Net Profit/Loss - EUR | - | - | 4.569 | 19.151 | 15.530 | 10.219 | 7.761 | 20.521 | 25.306 | 11.207 |
| Employees | - | - | 0 | 0 | 2 | 2 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Almiclinic Tm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 2.851 |
| Current Assets | - | - | 5.321 | 22.501 | 33.601 | 37.092 | 41.672 | 23.660 | 40.258 | 13.999 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 1.935 | 2.415 | 2.264 | 413 | 971 | 2.962 | 3.126 | 5.768 |
| Cash | - | - | 3.387 | 20.086 | 31.337 | 36.679 | 40.702 | 20.698 | 37.132 | 8.231 |
| Shareholders Funds | - | - | 4.613 | 21.530 | 32.429 | 35.831 | 40.775 | 20.562 | 37.719 | 11.247 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 711 | 970 | 1.172 | 1.262 | 897 | 3.098 | 2.539 | 5.603 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Almiclinic Tm Srl